Chlorogenic acid-inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells

被引:86
作者
Bandyopadhyay, G
Biswas, T
Roy, KC
Mandal, S
Mandal, C
Pal, BC
Bhattacharya, S
Rakshit, S
Bhattacharya, DK
Chaudhuri, U
Konar, A
Bandyopadhyay, S
机构
[1] Indian Inst Chem Biol, Div Immunol, Kolkata 700032, W Bengal, India
[2] Vivekananda Inst Med Sci, Kolkata, India
[3] Coll Med, Inst Haematol & Transfus Med, Kolkata, India
关键词
D O I
10.1182/blood-2003-11-4065
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report that chlorogenic acid (Chl) induces apoptosis of several Bcr-Abl-positive chronic myelogenous leukemia (CML) cell lines and primary cells from CML patients in vitro and destroys Bcr-Abl-positive K562 cells in vivo. In contrast, this compound has no effect on the growth and viability of Bcr-Abl-negative lymphocytic and myeloid cell lines and primary CMIL cells. Sodium chlorogenate (NaChl) exhibits 2-fold higher efficiency in killing K562 cells compared with Chl. NaChl also induces growth inhibition of squamous cell carcinoma (HSC-2) and salivary gland tumor cells (HSG), although at 50-fold higher concentration. NaChl inhibits autophosphorylation of p210(BCR-Abl) fusion protein rapidly. We demonstrate that p38 phosphorylation is increased in Bcr-Abl-positive cells after treatment with NaChl and closely paralleled the inhibition of Bcr-Abl phosphorylation. NaChl did not increase phosphorylation of p38 in Bcr-Abl-negative cells including HSC-2 and HSG that are responsive to this compound, indicating that p38 activation by NaChl is dependent on Bcr-Abl kinase inhibition. Inhibition of p38 activity by SB203580 significantly reduced NaChl-induced apoptosis of K562 cells, whereas activation of p38 by anisomycin augmented the apoptosis. These findings indicate that inhibition of Bcr-Abl kinase leading to activation of p38 mitogen-activated protein (MAP) kinase may play an important role in the anti-CML activity of Chl. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:2514 / 2522
页数:9
相关论文
共 51 条
[1]  
Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453
[2]  
BUCKINGHAM J, 1984, DICT ORGANIC COMPOUN
[3]   Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: Potential for pharmacodynamic monitoring of signal transduction inhibitors [J].
Chow, S ;
Patel, H ;
Hedley, DW .
CYTOMETRY, 2001, 46 (02) :72-78
[4]   EXPRESSION OF A DISTINCTIVE BCR-ABL ONCOGENE IN PH1-POSITIVE ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) [J].
CLARK, SS ;
MCLAUGHLIN, J ;
TIMMONS, M ;
PENDERGAST, AM ;
BEN-NERIAH, Y ;
DOW, LW ;
CRIST, W ;
ROVERA, G ;
SMITH, SD ;
WITTE, ON .
SCIENCE, 1988, 239 (4841) :775-777
[5]   SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1 [J].
CUENDA, A ;
ROUSE, J ;
DOZA, YN ;
MEIER, R ;
COHEN, P ;
GALLAGHER, TF ;
YOUNG, PR ;
LEE, JC .
FEBS LETTERS, 1995, 364 (02) :229-233
[6]   INDUCTION OF CHRONIC MYELOGENOUS LEUKEMIA IN MICE BY THE P210BCR/ABL GENE OF THE PHILADELPHIA-CHROMOSOME [J].
DALEY, GQ ;
VANETTEN, RA ;
BALTIMORE, D .
SCIENCE, 1990, 247 (4944) :824-830
[7]  
DeSilva DR, 1998, J IMMUNOL, V160, P4175
[8]   Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells [J].
Druker, BJ ;
Tamura, S ;
Buchdunger, E ;
Ohno, S ;
Segal, GM ;
Fanning, S ;
Zimmermann, J ;
Lydon, NB .
NATURE MEDICINE, 1996, 2 (05) :561-566
[9]   A SYNTHETIC INHIBITOR OF THE MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE [J].
DUDLEY, DT ;
PANG, L ;
DECKER, SJ ;
BRIDGES, AJ ;
SALTIEL, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :7686-7689
[10]   12-O-tetradecanoylphorbol-13-acetate activates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of SOS involving serine phosphorylation of Shc in NIH3T3 cells [J].
El-Shemerly, MYM ;
Besser, D ;
Nagasawa, M ;
Nagamine, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :30599-30602